EP1104486A4 - NEW METHOD FOR DIAGNOSING, MONITORING, STADIUM CLASSIFICATION, IMAGING AND TREATING LUNG CANCER - Google Patents

NEW METHOD FOR DIAGNOSING, MONITORING, STADIUM CLASSIFICATION, IMAGING AND TREATING LUNG CANCER

Info

Publication number
EP1104486A4
EP1104486A4 EP99935685A EP99935685A EP1104486A4 EP 1104486 A4 EP1104486 A4 EP 1104486A4 EP 99935685 A EP99935685 A EP 99935685A EP 99935685 A EP99935685 A EP 99935685A EP 1104486 A4 EP1104486 A4 EP 1104486A4
Authority
EP
European Patent Office
Prior art keywords
diagnosing
imaging
monitoring
lung cancer
new method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99935685A
Other languages
German (de)
French (fr)
Other versions
EP1104486A1 (en
Inventor
Fei Yang
Yongming Sun
Herve Recipon
Roberto A Macina
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diadexus Inc
Original Assignee
Diadexus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diadexus Inc filed Critical Diadexus Inc
Publication of EP1104486A1 publication Critical patent/EP1104486A1/en
Publication of EP1104486A4 publication Critical patent/EP1104486A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/14Peptides, e.g. proteins
    • A61K49/16Antibodies; Immunoglobulins; Fragments thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Radiology & Medical Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Optics & Photonics (AREA)
  • Zoology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP99935685A 1998-08-04 1999-07-19 NEW METHOD FOR DIAGNOSING, MONITORING, STADIUM CLASSIFICATION, IMAGING AND TREATING LUNG CANCER Withdrawn EP1104486A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9523398P 1998-08-04 1998-08-04
US95233P 1998-08-04
PCT/US1999/016247 WO2000008206A1 (en) 1998-08-04 1999-07-19 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer

Publications (2)

Publication Number Publication Date
EP1104486A1 EP1104486A1 (en) 2001-06-06
EP1104486A4 true EP1104486A4 (en) 2002-07-17

Family

ID=22250833

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99935685A Withdrawn EP1104486A4 (en) 1998-08-04 1999-07-19 NEW METHOD FOR DIAGNOSING, MONITORING, STADIUM CLASSIFICATION, IMAGING AND TREATING LUNG CANCER

Country Status (4)

Country Link
EP (1) EP1104486A4 (en)
JP (1) JP3524061B2 (en)
CA (1) CA2347656A1 (en)
WO (1) WO2000008206A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6869592B1 (en) 1998-08-04 2005-03-22 Diadexus, Inc. Method and antibody for imaging lung cancer
US20030017468A1 (en) * 2000-08-28 2003-01-23 Sei-Yu Chen Compositions and methods relating to lung specific genes
JP2004520821A (en) * 2000-10-26 2004-07-15 ディアデクサス インコーポレーテッド Compositions and methods for lung-specific genes and proteins
US20020160388A1 (en) * 2000-11-20 2002-10-31 Roberto Macina Compositions and methods relating to lung specific genes and proteins
JP2004520831A (en) * 2000-11-20 2004-07-15 ディアデクサス インコーポレーテッド Compositions and methods for lung-specific genes and proteins
WO2002068633A2 (en) * 2000-11-22 2002-09-06 Diadexus, Inc. Compositions and methods relating to lung specific genes and proteins
DE10254601A1 (en) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Gene products differentially expressed in tumors and their use
DE102004024617A1 (en) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentially expressed in tumors gene products and their use
EP1790664A1 (en) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoclonal antibodies against claudin-18 for treatment of cancer
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis
WO2014075788A1 (en) 2012-11-13 2014-05-22 Biontech Ag Agents for treatment of claudin expressing cancer diseases
GB2630774A (en) * 2023-06-07 2024-12-11 Curenetics Ltd Lung cancer biomarkers

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0695760A1 (en) * 1994-08-05 1996-02-07 F. Hoffmann-La Roche Ag Novel tumor marker for lung cancer
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
WO1998020143A1 (en) * 1996-11-05 1998-05-14 Abbott Laboratories Reagents and methods useful for detecting diseases of the lung
WO1998056951A1 (en) * 1997-06-11 1998-12-17 Abbott Laboratories Reagents and methods useful for detecting diseases of the lung
WO1999060160A1 (en) * 1998-05-21 1999-11-25 Diadexus Llc A novel method of diagnosing, monitoring, and staging lung cancer

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
EP0695760A1 (en) * 1994-08-05 1996-02-07 F. Hoffmann-La Roche Ag Novel tumor marker for lung cancer
WO1998020143A1 (en) * 1996-11-05 1998-05-14 Abbott Laboratories Reagents and methods useful for detecting diseases of the lung
WO1998056951A1 (en) * 1997-06-11 1998-12-17 Abbott Laboratories Reagents and methods useful for detecting diseases of the lung
WO1999060160A1 (en) * 1998-05-21 1999-11-25 Diadexus Llc A novel method of diagnosing, monitoring, and staging lung cancer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0008206A1 *

Also Published As

Publication number Publication date
JP3524061B2 (en) 2004-04-26
JP2002522046A (en) 2002-07-23
WO2000008206A1 (en) 2000-02-17
EP1104486A1 (en) 2001-06-06
CA2347656A1 (en) 2000-02-17

Similar Documents

Publication Publication Date Title
EP1104486A4 (en) NEW METHOD FOR DIAGNOSING, MONITORING, STADIUM CLASSIFICATION, IMAGING AND TREATING LUNG CANCER
EP1090291A4 (en) METHOD OF EARLY DIAGNOSIS OF CANCER AND DETERMINATION OF PROGNOSIS THEREOF
EP1455645A4 (en) METHOD AND SYSTEM FOR PROCESSING ELECTROCARDIOGRAMS
FR2743642B1 (en) METHOD AND APPARATUS FOR DIAGNOSING ABNORMALITIES OF A SYSTEM
EP1107798A4 (en) NEW METHOD FOR DIAGNOSING, MONITORING, STADIUM CLASSIFICATION, IMAGING AND TREATING COLON CANCER
EP1459243A4 (en) METHOD AND SYSTEM FOR IMAGE ANALYSIS REPORT
AU4407996A (en) Neural network method and apparatus for disease, injury and bodily condition screening or sensing
EP1049088A4 (en) SYSTEM, DEVICE AND METHOD FOR PROCESSING INFORMATION
EP1075219A4 (en) APPARATUS AND METHOD FOR FACILITATING HEMOSTASIS ON A BIOPSY PATH
EP1309902A4 (en) SYSTEM AND METHOD FOR MONITORING AND CONTROLLING POWER DISTRIBUTION
EP1366460A4 (en) METHOD AND SYSTEM FOR DETECTION OF FECAL MATERIALS AND INGESTA DURING THE TREATMENT OF MEAT AND POULTRY
EP0831924A4 (en) METHOD FOR TREATING ASTHMA
EP1007535A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING BREAST CANCER
FR2837053B1 (en) METHOD AND SYSTEM FOR BI OR MULTI-ENERGETIC IMAGING
EP1056346A4 (en) METHOD AND SYSTEM FOR PILING ANIMALS
EP1229834A4 (en) SYSTEM AND METHOD FOR QUANTITATIVE AND QUALITATIVE HAND ANALYSIS
FR2658617B1 (en) DEVICE AND METHOD FOR IDENTIFYING AND QUANTIFYING HYDROMETEORES BY DOPPLER EFFECT.
FR2792430B1 (en) SYSTEM AND METHOD FOR MONITORING IMAGE FORMING APPARATUS
EP1066408A4 (en) NOVEL METHOD FOR DETECTION AND MONITORING OF ENDOMETRIAL OR UTERINE CANCER
EP0986340A4 (en) OPAQUE X-RAY SOLUTION FOR VISUALIZING DENTAL ANATOMY AND AREAS PRESENTING PATHOLOGICAL CONDITIONS AND IATROGENIC DISORDERS, AND METHOD OF USING THE SAME
FR2835936B1 (en) METHOD AND SYSTEM FOR ANALYZING SOFTWARE LOCKING EVENTS
EP1001405A4 (en) IMAGE PROCESSING METHOD AND IMAGE DISPLAY
FR2774785B1 (en) AN APPLICATION MANAGEMENT METHOD AND INFORMATION PROCESSING APPARATUS USING THE METHOD
EP0805972A4 (en) Method and apparatus for diagnosis, detection of cell abnormalities and morphology of living systems
FR2765591B1 (en) METHOD FOR DIAGNOSING ALZHEIMER'S DISEASE

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010305

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020604

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7G 01N 33/574 A, 7C 07K 16/30 B, 7C 12Q 1/68 B, 7A 61K 39/395 B

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: DIADEXUS, INC.

17Q First examination report despatched

Effective date: 20030630

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050924